| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.9B | $3.8B | $3.3B | $2.8B | $2.6B | $2.5B | $4.7B | — |
| Cost of Revenue | $0.8B | $0.7B | $0.6B | $0.4B | $0.4B | $0.4B | $1.1B | $1.0B |
| Gross Profit | $3.2B | $3.1B | $2.7B | $2.4B | $2.2B | $2.1B | $3.7B | $3.8B |
| R&D Expense | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.9B | $1.0B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.6B | $1.1B | $1.2B | $1.0B | $0.9B | $0.4B | $0.4B | $0.0B |
| Net Income | $0.6B | $0.6B | $1.3B | $0.8B | $0.6B | $3.9B | $0.0B | $1.1B |
| EPS (Basic) | $1.04 | $0.97 | $2.20 | $1.44 | $0.94 | $6.32 | $0.05 | $1.85 |
| EPS (Diluted) | $1.03 | $0.96 | $2.16 | $1.41 | $0.92 | $6.05 | $0.05 | $1.70 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.5B | $15.8B | $15.9B | $6.9B | $6.4B | $7.7B | $15.9B | $15.8B |
| Current Assets | $1.4B | $1.4B | $1.2B | $2.3B | $1.5B | $3.1B | $3.2B | $3.5B |
| Cash & Equivalents | $1.0B | $0.8B | $0.8B | $1.9B | $0.9B | $2.2B | $1.8B | $1.8B |
| Total Liabilities | $13.2B | $13.6B | $13.7B | $7.0B | $6.9B | $7.7B | $10.2B | $10.7B |
| Current Liabilities | $2.9B | $2.6B | $2.8B | $3.1B | $2.1B | $2.6B | $3.8B | $3.2B |
| Stockholders' Equity | $2.3B | $2.2B | $2.2B | $-0.1B | $-0.5B | $0.0B | $5.7B | $5.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $2.1B | $0.8B | $1.0B | $0.7B | $-0.9B | $1.5B | $0.9B |
| Investing Cash Flow | $-0.1B | $0.0B | $-6.5B | $0.3B | $-0.1B | $11.4B | $-0.2B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.2B | $0.1B |
| Financing Cash Flow | $-1.0B | $-2.0B | $4.7B | $-0.3B | $-1.9B | $-10.1B | $-1.2B | $-3.5B |